Novartis Investigative Site
Las Palmas de Gran C, Las Palmas 35016
1 studies enrolling now · 3 studies all time
What they study most
Healthy Volunteers, Pulmonary Arterial Hypertension, Non-small Cell Lung Cancer, Primary Prevention of Atherosclerotic Cardiovascular Disease
Studies at this site
- A Study to Learn About the Treatment LTP001 in Healthy Participants (Part A) and in Participants With PAH (Part B) — Recruiting now
- A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients. — Running, not enrolling
- Study of Efficacy and Safety of Pembrolizumab Plus Platinum-based Doublet Chemotherapy With or Without Canakinumab in Previously Untreated Locally Advanced or Metastatic Non-squamous and Squamous NSCLC Subjects — Stopped early